Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Initiation
Biomea Fusion initiated with a Buy at Jefferies » 08:04
05/11/21
05/11
08:04
05/11/21
08:04
BMEA

Biomea Fusion

$16.45 /

-0.51 (-3.01%)

Jefferies analyst Eun…

Jefferies analyst Eun Yang initiated coverage of Biomea Fusion with a Buy rating and $26 price target. The preclinical-stage company is developing irreversible inhibitors for cancers using its proprietary FUSION System discovery platform and its lead candidate, BMF-219, has the potential for superior potency, Yang tells investors. The analyst expects initial human efficacy/safety data for BMF-219 in the second half of 2022 and sees a new cancer drug candidate to be announced in the first half of next year.

ShowHide Related Items >><<
BMEA Biomea Fusion
$16.45 /

-0.51 (-3.01%)

05/11/21 JPMorgan
Biomea Fusion initiated with an Overweight at JPMorgan
05/11/21 Jefferies
Biomea Fusion initiated with a Buy at Jefferies
05/11/21 Piper Sandler
Biomea Fusion initiated with an Overweight at Piper Sandler
  • 16
    Apr
BMEA Biomea Fusion
$16.45 /

-0.51 (-3.01%)

Initiation
Biomea Fusion initiated with an Overweight at JPMorgan » 07:11
05/11/21
05/11
07:11
05/11/21
07:11
BMEA

Biomea Fusion

$16.45 /

-0.51 (-3.01%)

JPMorgan analyst Gavin…

JPMorgan analyst Gavin Scott initiated coverage of Biomea Fusion with an Overweight rating and $26 price target. The company's proprietary FUSION system discovery platform has broad potential across many tumor targets with meaningful advantages when compared with other small molecule approaches, Scott tells investors in a research note. The analyst says Biomea has preclinical data that demonstrate anti-tumor activity and potential differentiation from two current comps that are in the clinic.

ShowHide Related Items >><<
BMEA Biomea Fusion
$16.45 /

-0.51 (-3.01%)

05/11/21 Jefferies
Biomea Fusion initiated with a Buy at Jefferies
05/11/21 Piper Sandler
Biomea Fusion initiated with an Overweight at Piper Sandler
  • 16
    Apr
BMEA Biomea Fusion
$16.45 /

-0.51 (-3.01%)

Initiation
Biomea Fusion initiated with a Buy at Jefferies » 06:11
05/11/21
05/11
06:11
05/11/21
06:11
BMEA

Biomea Fusion

$16.45 /

-0.51 (-3.01%)

Jefferies analyst Eun…

Jefferies analyst Eun Yang initiated coverage of Biomea Fusion with a Buy rating and $26 price target.

ShowHide Related Items >><<
BMEA Biomea Fusion
$16.45 /

-0.51 (-3.01%)

05/11/21 Piper Sandler
Biomea Fusion initiated with an Overweight at Piper Sandler
  • 16
    Apr
BMEA Biomea Fusion
$16.45 /

-0.51 (-3.01%)

Initiation
Biomea Fusion initiated with an Overweight at Piper Sandler » 04:55
05/11/21
05/11
04:55
05/11/21
04:55
BMEA

Biomea Fusion

$16.45 /

-0.51 (-3.01%)

Piper Sandler analyst…

Piper Sandler analyst Joseph Catanzaro initiated coverage of Biomea Fusion with an Overweight rating and $27 price target. The analyst views the FUSION System discovery platform to be positioned to generate best-in-class inhibitors via irreversible covalent interactions. Biomea's lead program BMF-219 is an irreversible menin inhibitor that has proven in preclinical studies to be much more potent and drive more robust anti-tumor activity than reversible inhibitors, Catanzaro tells investors in a research note.

ShowHide Related Items >><<
  • 16
    Apr
BMEA Biomea Fusion
$16.45 /

-0.51 (-3.01%)

Over a week ago
On The Fly
Opening Day: Coinbase soars in market debut » 09:03
04/17/21
04/17
09:03
04/17/21
09:03
RXRX

Recursion Pharmaceuticals

$31.06 /

+0.81 (+2.68%)

, BMEA

Biomea Fusion

$18.48 /

-1.92 (-9.41%)

, AKYA

Akoya Biosciences

$26.92 /

+0.18 (+0.67%)

, APP

AppLovin

$61.01 /

-3.795 (-5.86%)

, AGL

Agilon Health

$30.45 /

-0.43 (-1.39%)

, KRT

Karat Packaging

$18.38 /

-0.52 (-2.75%)

, TSP

TuSimple

$39.99 /

+0.53 (+1.34%)

, EBET

Esports Technologies

$25.35 /

-10.69 (-29.66%)

, COIN

Coinbase

$341.27 /

+15.78 (+4.85%)

, ALKT

Alkami

$42.13 /

-0.13 (-0.31%)

, SQSP

Squarespace

/

+

, SVFD

Save Foods

/

+

, RGCB

Regencell Bioscience

/

+

, SWIM

Latham Group

/

+

, EDR

Endeavor

$41.49 /

+ (+0.00%)

, UBER

Uber

$60.34 /

-0.405 (-0.67%)

, LYFT

Lyft

$63.36 /

-1.07 (-1.66%)

Shares of Coinbase jumped…

ShowHide Related Items >><<
UBER Uber
$60.34 /

-0.405 (-0.67%)

LYFT Lyft
$63.36 /

-1.07 (-1.66%)

COIN Coinbase
$341.27 /

+15.78 (+4.85%)

RXRX Recursion Pharmaceuticals
$31.06 /

+0.81 (+2.68%)

BMEA Biomea Fusion
$18.48 /

-1.92 (-9.41%)

AKYA Akoya Biosciences
$26.92 /

+0.18 (+0.67%)

APP AppLovin
$61.01 /

-3.795 (-5.86%)

AGL Agilon Health
$30.45 /

-0.43 (-1.39%)

KRT Karat Packaging
$18.38 /

-0.52 (-2.75%)

TSP TuSimple
$39.99 /

+0.53 (+1.34%)

EBET Esports Technologies
$25.35 /

-10.69 (-29.66%)

COIN Coinbase
$341.27 /

+15.78 (+4.85%)

04/15/21 Loop Capital
Loop Capital starts Coinbase at Buy, sees 'lots of runway before takeoff'
04/15/21 Loop Capital
Coinbase initiated with a Buy at Loop Capital
04/15/21
Fly Intel: Top five analyst initiations
04/15/21 DA Davidson
Coinbase price target raised to $650 from $440 at DA Davidson
ALKT Alkami
$42.13 /

-0.13 (-0.31%)

SQSP Squarespace
/

+

SVFD Save Foods
/

+

RGCB Regencell Bioscience
/

+

SWIM Latham Group
/

+

EDR Endeavor
$41.49 /

+ (+0.00%)

UBER Uber
$60.34 /

-0.405 (-0.67%)

04/12/21 Truist
Uber's March update 'bodes well' for Q1 and FY21 outlook, says Truist
04/05/21 Evercore ISI
Uber assumed with an Outperform at Evercore ISI
04/01/21
Fly Intel: Top five analyst initiations
04/01/21 Jefferies
Uber initiated with a Buy at Jefferies
LYFT Lyft
$63.36 /

-1.07 (-1.66%)

04/05/21 Evercore ISI
Lyft assumed with an Outperform at Evercore ISI
03/31/21 Wolfe Research
Lyft assumed with a Peer Perform at Wolfe Research
03/26/21
Fly Intel: Top five analyst initiations
03/26/21 Vertical Research
Lyft initiated with a Buy at Vertical Research
UBER Uber
$60.34 /

-0.405 (-0.67%)

LYFT Lyft
$63.36 /

-1.07 (-1.66%)

COIN Coinbase
$341.27 /

+15.78 (+4.85%)

  • 23
    Apr
  • 14
    Apr
  • 15
    Apr
  • 16
    Apr
  • 16
    Apr
  • 16
    Apr
  • 15
    Apr
  • 15
    Apr
  • 15
    Apr
  • 14
    Apr
  • 15
    Apr
  • 08
    Jan
UBER Uber
$60.34 /

-0.405 (-0.67%)

TSP TuSimple
$39.99 /

+0.53 (+1.34%)

LYFT Lyft
$63.36 /

-1.07 (-1.66%)

COIN Coinbase
$341.27 /

+15.78 (+4.85%)

UBER Uber
$60.34 /

-0.405 (-0.67%)

SQSP Squarespace
/

+

LYFT Lyft
$63.36 /

-1.07 (-1.66%)

EBET Esports Technologies
$25.35 /

-10.69 (-29.66%)

COIN Coinbase
$341.27 /

+15.78 (+4.85%)

AGL Agilon Health
$30.45 /

-0.43 (-1.39%)

UBER Uber
$60.34 /

-0.405 (-0.67%)

LYFT Lyft
$63.36 /

-1.07 (-1.66%)

Syndicate
Biomea Fusion opens at $20, IPO priced at $17 per share  11:52
04/16/21
04/16
11:52
04/16/21
11:52
BMEA

Biomea Fusion

/

+

 
ShowHide Related Items >><<
  • 16
    Apr
Syndicate
Biomea Fusion indicated to open at $22, IPO priced at $17 » 10:48
04/16/21
04/16
10:48
04/16/21
10:48
BMEA

Biomea Fusion

/

+

Biomea Fusion (BMEA)…

Biomea Fusion (BMEA) priced 9M shares at $17.00. The deal size was increased to 9M shares from 7.5M shares and priced at the high-end of the $15.00-$17.00 range. JPMorgan, Jefferies and Piper Sandler acted as joint book running managers for the offering.

ShowHide Related Items >><<
  • 16
    Apr
Syndicate
Biomea Fusion 9M share IPO priced at $17.00 » 06:32
04/16/21
04/16
06:32
04/16/21
06:32
BMEA

Biomea Fusion

/

+

The deal size was…

The deal size was increased to 9M shares from 7.5M shares and priced at the high-end of the $15.00-$17.00 range. JPMorgan, Jefferies and Piper Sandler acted as joint book running managers for the offering.

ShowHide Related Items >><<
  • 16
    Apr
Syndicate
Biomea Fusion 7.5M share IPO price range $15.00-$17.00 » 10:46
04/12/21
04/12
10:46
04/12/21
10:46
BMEA

Biomea Fusion

/

+

JPMorgan, Jefferies and…

JPMorgan, Jefferies and Piper Sandler are acting as joint book running managers for the offering.

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.